RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
RT @LuisAlberto3P: Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachyther…
Patient alert: If you are <60 y.o. and you need treatment for localized favourable #ProstateCancer, consider #brachytherapy, a treatment modality with unmatched rates of functional preservation and excellent oncological results. I did it! I'm oncologist
RT @Isoray: "LDR #brachytherapy provides patients younger than 60 years of age with low and intermediate-risk #prostatecancer excellent out…
RT @Isoray: "LDR #brachytherapy provides patients younger than 60 years of age with low and intermediate-risk #prostatecancer excellent out…
"LDR #brachytherapy provides patients younger than 60 years of age with low and intermediate-risk #prostatecancer excellent outcomes..." Read more here. https://t.co/qBrMSmqlFF
RT @IDIVALdireccion: Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer. #valdecill…
RT @IDIVALdireccion: Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer. #valdecill…
RT @IDIVALdireccion: Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer. #valdecill…
Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer. #valdecilla reference in #brachytherapy https://t.co/uUe96VyTOt